These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3194959)

  • 1. Effect of combination therapy of vitamin K1 and ursodeoxycholic acid on liver function tests.
    Iijima T; Nambu M
    Trop Gastroenterol; 1988; 9(3):139-44. PubMed ID: 3194959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ursodeoxycholic acid lowers liver enzymes].
    Leuschner U
    Leber Magen Darm; 1989 Sep; 19(5):276. PubMed ID: 2811579
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
    Lirussi F; Okolicsanyi L
    Acta Physiol Hung; 1992; 80(1-4):363-7. PubMed ID: 1345202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
    Leuschner U; Fischer H; Hübner K
    Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ursodeoxycholic acid in primary biliary cirrhosis. 2: Prospective long-term study of 21 patients].
    Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
    Fortschr Med; 1988 Nov; 106(34):695-8. PubMed ID: 3145247
    [No Abstract]   [Full Text] [Related]  

  • 6. [Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity--a pilot study].
    Janowitz P; Kratzer W; Wechsler JG
    Leber Magen Darm; 1996 Nov; 26(6):310-3. PubMed ID: 9082112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].
    Stiehl A; Raedsch R
    Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928
    [No Abstract]   [Full Text] [Related]  

  • 8. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V; Michael S; Prego V
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination therapy of vitamin K1 and bile acid on hemorrhagic diathesis in patients with decompensated liver cirrhosis.
    Nambu M; Iijima T
    Gastroenterol Jpn; 1988 Apr; 23(2):160-4. PubMed ID: 3384277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.
    Osuga T; Tanaka N; Matsuzaki Y; Aikawa T
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):49S-51S. PubMed ID: 2574657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid on liver structure in man. Quantitative data.
    Koch MM; Giampieri MP; Lorenzini I; Jézéquel AM; Orlandi F
    Gastroenterol Clin Biol; 1980; 4(8-9):560-8. PubMed ID: 7429103
    [No Abstract]   [Full Text] [Related]  

  • 14. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current viewpoints in the drug therapy of gallstones].
    van Berge Henegouwen GP; van der Werf SD; Schalm SW
    Ned Tijdschr Geneeskd; 1983 Oct; 127(43):1965-9. PubMed ID: 6656899
    [No Abstract]   [Full Text] [Related]  

  • 16. Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial.
    Del Vecchio Blanco C; Caporaso N; Gentile S; Rinaldi M; Pucci R
    J Int Med Res; 1982; 10(4):278-82. PubMed ID: 7117685
    [No Abstract]   [Full Text] [Related]  

  • 17. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: first controlled data.
    Borum M; Fromm H
    Hepatology; 1990 Jul; 12(1):172-3. PubMed ID: 2197211
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical dissolution of gallstones.
    Tandon RK; Mittal A
    J Assoc Physicians India; 1987 Oct; 35(10):699-702. PubMed ID: 3446679
    [No Abstract]   [Full Text] [Related]  

  • 19. Ursodeoxycholic acid in the treatment of chronic liver disease.
    Cirillo NW; Zwas FR
    Am J Gastroenterol; 1994 Sep; 89(9):1447-52. PubMed ID: 8079918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.